Stockreport

Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2 [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The U.S. FDA Wednesday updated the drug shortage status for the two medications. Only one dosage strength of Mounjaro and Zepbound have normal availability. Tirzepa [Read more]